HIGHLIGHTS
- who: Nicole D. Armstrong et al. from the Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA have published the research: Genetic Contributors of Efficacy and Adverse Metabolic Effects of Chlorthalidone in African Americans from the Genetics of Hypertension Associated Treatments (GenHAT) Study, in the Journal: Genes 2022, 1260 of 21/05/2021
- what: Utilizing data from 4297 AA participants randomized to chlorthalidone from the Genetics of Hypertension Associated Treatments (GenHAT) study the authors aimed to identify variants associated with the efficacy of chlorthalidone. This study focuses on 7593 GenHAT participants with genome . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.